These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 11981761)

  • 21. A cyclooxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug enhances the growth inhibitory effect of butyrate in colorectal carcinoma cells expressing COX-2 protein: regulation of COX-2 by butyrate.
    Crew TE; Elder DJ; Paraskeva C
    Carcinogenesis; 2000 Jan; 21(1):69-77. PubMed ID: 10607736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398.
    Bae SH; Jung ES; Park YM; Kim BS; Kim BK; Kim DG; Ryu WS
    Clin Cancer Res; 2001 May; 7(5):1410-8. PubMed ID: 11350912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells.
    Han S; Inoue H; Flowers LC; Sidell N
    Clin Cancer Res; 2003 Oct; 9(12):4627-35. PubMed ID: 14555539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emodin suppresses hyaluronic acid-induced MMP-9 secretion and invasion of glioma cells.
    Kim MS; Park MJ; Kim SJ; Lee CH; Yoo H; Shin SH; Song ES; Lee SH
    Int J Oncol; 2005 Sep; 27(3):839-46. PubMed ID: 16077936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases.
    Attiga FA; Fernandez PM; Weeraratna AT; Manyak MJ; Patierno SR
    Cancer Res; 2000 Aug; 60(16):4629-37. PubMed ID: 10969817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibited proliferation of cyclooxygenase-2 expressing human hepatoma cells by NS-398, a selective COX-2 inhibitor.
    Hu KQ; Yu CH; Mineyama Y; McCracken JD; Hillebrand DJ; Hasan M
    Int J Oncol; 2003 Apr; 22(4):757-63. PubMed ID: 12632065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coexpression of proangiogenic factors IL-8 and VEGF by human head and neck squamous cell carcinoma involves coactivation by MEK-MAPK and IKK-NF-kappaB signal pathways.
    Bancroft CC; Chen Z; Dong G; Sunwoo JB; Yeh N; Park C; Van Waes C
    Clin Cancer Res; 2001 Feb; 7(2):435-42. PubMed ID: 11234901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potentiation of the antitumor effects of both selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatic cancer cells by inhibition of the MEK/ERK pathway.
    Cusimano A; Foderà D; D'Alessandro N; Lampiasi N; Azzolina A; Montalto G; Cervello M
    Cancer Biol Ther; 2007 Sep; 6(9):1461-8. PubMed ID: 18424914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NS-398 and piroxicam suppress UVB-induced activator protein 1 activity by mechanisms independent of cyclooxygenase-2.
    Liu G; Ma WY; Bode AM; Zhang Y; Dong Z
    J Biol Chem; 2003 Jan; 278(4):2124-30. PubMed ID: 12433932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Naringenin suppresses TPA-induced tumor invasion by suppressing multiple signal transduction pathways in human hepatocellular carcinoma cells.
    Yen HR; Liu CJ; Yeh CC
    Chem Biol Interact; 2015 Jun; 235():1-9. PubMed ID: 25866363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing.
    Jones MK; Wang H; Peskar BM; Levin E; Itani RM; Sarfeh IJ; Tarnawski AS
    Nat Med; 1999 Dec; 5(12):1418-23. PubMed ID: 10581086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased NF-kappaB DNA binding but not transcriptional activity during apoptosis induced by the COX-2-selective inhibitor NS-398 in colorectal carcinoma cells.
    Smartt HJ; Elder DJ; Hicks DJ; Williams NA; Paraskeva C
    Br J Cancer; 2003 Oct; 89(7):1358-65. PubMed ID: 14520472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of ERK and JNK pathways in regulating cell motility and matrix metalloproteinase 9 production in growth factor-stimulated human epidermal keratinocytes.
    Zeigler ME; Chi Y; Schmidt T; Varani J
    J Cell Physiol; 1999 Aug; 180(2):271-84. PubMed ID: 10395297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sorafenib inhibits migration and invasion of hepatocellular carcinoma cells through suppression of matrix metalloproteinase expression.
    Ha TY; Hwang S; Moon KM; Won YJ; Song GW; Kim N; Tak E; Ryoo BY; Hong HN
    Anticancer Res; 2015 Apr; 35(4):1967-76. PubMed ID: 25862849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heparin inhibits Hepatocyte Growth Factor induced motility and invasion of hepatocellular carcinoma cells through early growth response protein 1.
    Ozen E; Gozukizil A; Erdal E; Uren A; Bottaro DP; Atabey N
    PLoS One; 2012; 7(8):e42717. PubMed ID: 22912725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ROCK and nuclear factor-kappaB-dependent activation of cyclooxygenase-2 by Rho GTPases: effects on tumor growth and therapeutic consequences.
    Benitah SA; Valerón PF; Lacal JC
    Mol Biol Cell; 2003 Jul; 14(7):3041-54. PubMed ID: 12857884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytokine-suppressive anti-inflammatory drugs (CSAIDs) inhibit invasion and MMP-1 production of ovarian carcinoma cells.
    Denkert C; Koch I; Berger S; Köbel M; Siegert A; Hauptmann S
    Cancer Lett; 2003 May; 195(1):101-9. PubMed ID: 12767518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential regulation of the phosphoinositide 3-kinase and MAP kinase pathways by hepatocyte growth factor vs. insulin-like growth factor-I in myogenic cells.
    Halevy O; Cantley LC
    Exp Cell Res; 2004 Jul; 297(1):224-34. PubMed ID: 15194438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aspirin inhibits tumor cell invasiveness induced by Epstein-Barr virus latent membrane protein 1 through suppression of matrix metalloproteinase-9 expression.
    Murono S; Yoshizaki T; Sato H; Takeshita H; Furukawa M; Pagano JS
    Cancer Res; 2000 May; 60(9):2555-61. PubMed ID: 10811139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NS-398, a selective cyclooxygenase 2 inhibitor, inhibited cell growth and induced cell cycle arrest in human hepatocellular carcinoma cell lines.
    Cheng J; Imanishi H; Amuro Y; Hada T
    Int J Cancer; 2002 Jun; 99(5):755-61. PubMed ID: 12115513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.